EdgarLookup

KEMPER Corp — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that KEMPER Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
3%
Profit Margin
Net income ÷ revenue
1.1%
Return on Assets
Net income ÷ assets
3.66x
Debt-to-Equity
Total liabilities ÷ equity
+3.3%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.79B Feb 11, 2026
FY2025 Dec 31, 2024 $4.64B Feb 11, 2026
FY2025 Dec 31, 2023 $4.94B Feb 11, 2026
FY2024 Dec 31, 2022 $5.52B Feb 7, 2025
FY2023 Dec 31, 2021 $5.72B Feb 7, 2024
FY2020 Dec 31, 2020 $1.39B Feb 10, 2021
FY2020 Sep 30, 2020 $1.35B Feb 10, 2021
FY2020 Jun 30, 2020 $1.23B Feb 10, 2021
FY2020 Mar 31, 2020 $1.23B Feb 10, 2021
FY2020 Dec 31, 2019 $1.28B Feb 10, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $143.30M Feb 11, 2026
FY2025 Dec 31, 2024 $317.80M Feb 11, 2026
FY2025 Dec 31, 2023 ($272.10M) Feb 11, 2026
FY2024 Dec 31, 2022 ($286.60M) Feb 7, 2025
FY2023 Dec 31, 2021 ($123.70M) Feb 7, 2024
FY2020 Dec 31, 2020 $97.50M Feb 10, 2021
FY2020 Sep 30, 2020 $122.30M Feb 10, 2021
FY2020 Jun 30, 2020 $126.10M Feb 10, 2021
FY2020 Mar 31, 2020 $64.00M Feb 10, 2021
FY2020 Dec 31, 2019 $124.70M Feb 10, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 ($68.90M) Feb 7, 2024
FY2023 Dec 31, 2022 ($166.60M) Feb 7, 2024
FY2023 Dec 31, 2021 ($334.00M) Feb 7, 2024
FY2022 Dec 31, 2020 $546.80M Feb 9, 2023
FY2021 Dec 31, 2019 $518.80M Feb 10, 2022
FY2020 Dec 31, 2018 $286.20M Feb 10, 2021
FY2019 Dec 31, 2017 $118.90M Feb 14, 2020
FY2018 Dec 31, 2016 $3.10M Feb 20, 2019
FY2017 Dec 31, 2015 $84.50M Feb 13, 2018
FY2016 Dec 31, 2014 $136.30M Feb 13, 2017

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $584.50M Feb 11, 2026
FY2025 Dec 31, 2024 $382.90M Feb 11, 2026
FY2025 Dec 31, 2023 ($134.20M) Feb 11, 2026
FY2024 Dec 31, 2022 ($210.30M) Feb 7, 2025
FY2023 Dec 31, 2021 $350.70M Feb 7, 2024
FY2022 Dec 31, 2020 $448.00M Feb 9, 2023
FY2021 Dec 31, 2019 $534.30M Feb 10, 2022
FY2020 Dec 31, 2018 $539.20M Feb 10, 2021
FY2019 Dec 31, 2017 $240.60M Feb 14, 2020
FY2018 Dec 31, 2016 $240.50M Feb 20, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $12.47B Feb 11, 2026
FY2025 Dec 31, 2024 $12.63B Feb 11, 2026
FY2025 Dec 31, 2023 $12.74B Feb 11, 2026
FY2024 Dec 31, 2022 $13.31B Feb 7, 2025
FY2022 Dec 31, 2021 $14.92B Feb 9, 2023
FY2021 Dec 31, 2020 $14.34B Feb 10, 2022
FY2020 Dec 31, 2019 $12.99B Feb 10, 2021
FY2019 Dec 31, 2018 $11.54B Feb 14, 2020
FY2018 Dec 31, 2017 $8.38B Feb 20, 2019
FY2017 Dec 31, 2016 $8.21B Feb 13, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $9.80B Feb 11, 2026
FY2025 Dec 31, 2024 $9.85B Feb 11, 2026
FY2024 Dec 31, 2023 $10.24B Feb 7, 2025
FY2023 Dec 31, 2022 $10.64B Feb 7, 2024
FY2022 Dec 31, 2021 $10.91B Feb 9, 2023
FY2021 Dec 31, 2020 $9.78B Feb 10, 2022
FY2020 Dec 31, 2019 $9.02B Feb 10, 2021
FY2019 Dec 31, 2018 $8.49B Feb 14, 2020
FY2018 Dec 31, 2017 $6.26B Feb 20, 2019
FY2017 Dec 31, 2016 $6.24B Feb 13, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.68B Feb 11, 2026
FY2025 Dec 31, 2024 $2.79B Feb 11, 2026
FY2024 Dec 31, 2023 $2.51B Feb 7, 2025
FY2025 Dec 31, 2022 $241.10M Feb 11, 2026
FY2024 Dec 31, 2021 ($849.70M) Feb 7, 2025
FY2021 Dec 31, 2020 $4.56B Feb 10, 2022
FY2020 Dec 31, 2019 $3.97B Feb 10, 2021
FY2019 Dec 31, 2018 $3.05B Feb 14, 2020
FY2018 Dec 31, 2017 $2.12B Feb 20, 2019
FY2017 Dec 31, 2016 $1.98B Feb 13, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.25B Feb 11, 2026
FY2025 Dec 31, 2024 $1.25B Feb 11, 2026
FY2024 Dec 31, 2023 $1.25B Feb 7, 2025
FY2023 Dec 31, 2022 $1.30B Feb 7, 2024
FY2022 Dec 31, 2021 $1.31B Feb 9, 2023
FY2021 Dec 31, 2020 $1.11B Feb 10, 2022
FY2020 Dec 31, 2019 $1.11B Feb 10, 2021
FY2019 Dec 31, 2018 $1.11B Feb 14, 2020
FY2018 Dec 31, 2017 $323.00M Feb 20, 2019
FY2017 Dec 31, 2016 $323.00M Feb 13, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.16B Feb 11, 2026
FY2025 Dec 31, 2024 $1.23B Feb 11, 2026
FY2024 Dec 31, 2023 $1.01B Feb 7, 2025
FY2023 Dec 31, 2022 $1.37B Feb 7, 2024
FY2022 Dec 31, 2021 $1.76B Feb 9, 2023
FY2021 Dec 31, 2020 $2.07B Feb 10, 2022
FY2020 Dec 31, 2019 $1.81B Feb 10, 2021
FY2019 Dec 31, 2018 $1.36B Feb 14, 2020
FY2018 Dec 31, 2017 $1.24B Feb 20, 2019
FY2017 Dec 31, 2016 $1.17B Feb 13, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $943.50M Feb 11, 2026
FY2025 Dec 31, 2024 $1.39B Feb 11, 2026
FY2024 Dec 31, 2023 $1.39B Feb 7, 2025
FY2023 Dec 31, 2022 $1.39B Feb 7, 2024
FY2022 Dec 31, 2021 $1.12B Feb 9, 2023
FY2021 Dec 31, 2020 $1.17B Feb 10, 2022
FY2020 Dec 31, 2019 $778.40M Feb 10, 2021
FY2019 Dec 31, 2018 $909.00M Feb 14, 2020
FY2018 Dec 31, 2017 $592.30M Feb 20, 2019
FY2017 Dec 31, 2016 $751.60M Feb 13, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Feb 11, 2026
FY2025 Dec 31, 2024 4 Feb 11, 2026
FY2025 Dec 31, 2023 (4) Feb 11, 2026
FY2024 Dec 31, 2022 (4) Feb 7, 2025
FY2023 Dec 31, 2021 (1) Feb 7, 2024
FY2020 Dec 31, 2020 1 Feb 10, 2021
FY2020 Sep 30, 2020 1 Feb 10, 2021
FY2020 Jun 30, 2020 1 Feb 10, 2021
FY2020 Mar 31, 2020 0 Feb 10, 2021
FY2020 Dec 31, 2019 1 Feb 10, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Feb 11, 2026
FY2025 Dec 31, 2024 4 Feb 11, 2026
FY2025 Dec 31, 2023 (4) Feb 11, 2026
FY2024 Dec 31, 2022 (4) Feb 7, 2025
FY2023 Dec 31, 2021 (1) Feb 7, 2024
FY2020 Dec 31, 2020 1 Feb 10, 2021
FY2020 Sep 30, 2020 1 Feb 10, 2021
FY2020 Jun 30, 2020 1 Feb 10, 2021
FY2020 Mar 31, 2020 0 Feb 10, 2021
FY2020 Dec 31, 2019 1 Feb 10, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 58.67M Feb 11, 2026
FY2025 Dec 31, 2024 63.84M Feb 11, 2026
FY2024 Dec 31, 2023 64.11M Feb 7, 2025
FY2023 Dec 31, 2022 63.91M Feb 7, 2024
FY2022 Dec 31, 2021 63.68M Feb 9, 2023
FY2021 Dec 31, 2020 65.44M Feb 10, 2022
FY2020 Dec 31, 2019 66.67M Feb 10, 2021
FY2019 Dec 31, 2018 64.76M Feb 14, 2020
FY2018 Dec 31, 2017 51.46M Feb 20, 2019
FY2017 Dec 31, 2016 51.27M Feb 13, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2020 Dec 31, 2020 $78.90M Feb 10, 2021
FY2018 Dec 31, 2018 $56.40M Feb 20, 2019
FY2018 Dec 31, 2017 $49.50M Feb 20, 2019
FY2018 Dec 31, 2016 $49.20M Feb 20, 2019
FY2017 Dec 31, 2015 $49.70M Feb 13, 2018
FY2016 Dec 31, 2014 $51.80M Feb 13, 2017
FY2015 Dec 31, 2013 $54.90M Feb 12, 2016
FY2014 Dec 31, 2012 $56.90M Feb 12, 2015
FY2013 Dec 31, 2011 $58.20M Feb 14, 2014
FY2010 Dec 31, 2010 $54.60M Feb 3, 2011